IGF-1 LR3: My 10-Day Burst Protocol for Direct Receptor Activation

Quick Summary

What it is: IGF-1 LR3 is a modified version of insulin-like growth factor 1 with an arginine substitution at position 3 and a 13-amino-acid N-terminal extension, giving it a 20–30 hour half-life vs. the 10-minute half-life of native IGF-1.
Mechanism: Direct IGF-1 receptor agonist. Activates PI3K/Akt/mTOR for protein synthesis and MAPK/ERK for satellite cell proliferation. Bypasses the GH axis entirely.
Who it’s for: Bodybuilders pushing past natural plateaus, athletes recovering from overreach, anyone running a high-protein bulking block who wants direct receptor activation without going through the pituitary.
Differentiator: Unlike GH or secretagogues, LR3 hits the receptor directly. No waiting for the liver to produce IGF-1. No GH side effects.
Natural Plus angle: The 10-day burst protocol I dialed in back in 2016 — short on, long off, calorie cycle the days, sodium chloride water for clean reconstitution. Pulsed signaling beats continuous dosing because the receptor stays sensitive.

What IGF-1 LR3 Actually Does Inside the Cell

Most articles on IGF-1 LR3 stay surface-level. They talk about “muscle growth” without explaining the receptor cascade. That’s lazy. If you understand the actual signaling, you understand why the protocol matters.

IGF-1 LR3 is an 83-amino-acid analog of native human IGF-1 (which is 70 amino acids). Two structural changes do all the work: a glutamic acid swapped for arginine at position 3, and 13 extra amino acids tacked onto the N-terminus. These changes drop binding affinity to IGF binding proteins (IGFBPs) by roughly 100-fold while keeping full affinity for the IGF-1 receptor itself.

That binding-protein evasion is the whole point. In your bloodstream, more than 99% of native IGF-1 is locked up in complexes with IGFBP-3 and the acid-labile subunit. Only the unbound fraction can hit a receptor. By engineering a molecule that the IGFBPs can’t grab, LR3 stays free and receptor-available. Half-life jumps from 10–15 minutes to 20–30 hours. Functional potency in vivo is 2–3x higher per molar dose than native IGF-1.

When LR3 binds the IGF-1 receptor (a transmembrane receptor tyrosine kinase), the receptor autophosphorylates and lights up two parallel pathways:

PI3K/Akt/mTOR: This is the protein synthesis lane. Akt activates mTOR, which drives ribosomal protein synthesis, cell growth, and anti-apoptotic signaling. It also moves GLUT4 transporters to the cell membrane, which is why blood glucose drops after a dose. This is the lane that builds muscle.

MAPK/ERK: This is the proliferation lane. It drives satellite cells out of quiescence and into the cell cycle by upregulating cyclin D1 and pushing cells through the G1/S checkpoint. Satellite cells are the precursor cells that fuse to existing muscle fibers and donate new nuclei. More nuclei means a higher ceiling for hypertrophy. This is the lane that lets you keep growing.

Both pathways run simultaneously. That’s why LR3 produces results that GH alone doesn’t. GH works upstream (it tells the liver to make IGF-1). LR3 hits the receptor directly. No pituitary, no liver, no waiting.

Tony Huge’s Laws of Biochemistry Physics: Self-Regulating Systems

Of the five Laws, the one that governs IGF-1 LR3 protocol design is Law 4: Self-Regulating Systems. The body fights to maintain homeostasis. Push a system one direction and feedback mechanisms push back.

With IGF-1 LR3, the feedback isn’t HPG axis suppression like you’d see with exogenous testosterone. There’s no PCT needed. The feedback is at the receptor itself. Continuous exposure to supraphysiological IGF-1 signaling causes receptor density on muscle cells to drop. Some research suggests 40–60% downregulation after 6 weeks of continuous daily dosing.

Think of it like a thermostat. Crank the heat constantly and the AC kicks in to fight back. With LR3, the cell pulls receptors off the membrane to dampen the signal. You’re still injecting the same dose but getting progressively less response.

The fix is anticipating counter-regulation instead of fighting it. Pulse the signal. Run the protocol short enough that receptors don’t have time to downregulate, then back off long enough that any partial downregulation fully reverses. That’s why my 10-day protocol works and continuous 8-week cycles don’t. You’re working with the regulatory system, not against it.

The Natural Plus Protocol — My 2016 Field-Tested IGF-1 LR3 Method

Here’s the protocol I dialed in back in 2016 after experimenting with longer cycles and watching them taper off in the second and third week. This is what I run.

Reconstitution

1mL of sodium chloride water for a 1mg vial. That’s it. The textbook move would be acetic acid as a preservative, and yeah, it gives you slightly better stability. But the injection burns. I traded a small potency loss for a more comfortable shot, and I’m fine with it. If you want maximum stability over a longer window, use bacteriostatic water or a mild acetic acid solution and accept the sting.

At 1mg in 1mL, that’s 1000 mcg/mL. So 100 mcg = 0.1mL = 10 IU on a U-100 insulin syringe. Easy math.

Dosing

100 mcg per day. Once daily. Subcutaneous on a slin pin. I prefer abs because it’s the easiest site and rotation is simple.

This sits at the upper end of the practical range. Most research protocols recommend 20–50 mcg/day for general anabolic effect. I run 100 mcg because I’m pushing for maximum response in a tight window, and the consensus is that side effect risk rises sharply above 100 mcg without proportional benefit. Below 100 mcg is the safer ceiling for most people. Don’t go above 100.

Cycle Length

10 days on. Then off. Long enough to drive sustained anabolic signaling. Short enough that the receptor never has time to downregulate. After 10 days, you take a break. Minimum 2–4 weeks before the next round, longer if you want full receptor reset.

Calorie Strategy

This is where most people screw it up. They run IGF-1 LR3 and don’t feed the system. The compound is telling every cell in your body to grow. If you don’t have substrate (protein and carbs), the signal goes wasted and you just get hypoglycemia.

On the 10 on-days: eat a lot more protein and a lot more carbs. Hard surplus. This is a growth phase. The IGF-1 receptor is moving GLUT4 to the cell membrane and pulling glucose in fast. Carbs feed that uptake. Protein gives the ribosomes substrate for the synthesis your mTOR signaling is screaming for.

After the 10 days, you can do a few lower-calorie days to tighten back up. The growth is locked in by then. Cutting a bit afterward leans you out and lets you start the next cycle anytime.

Variant: Alternating Days

If you want to extend the on-period without burning out the receptor, you can run 2 days on, 1 day off, and use the off-day as a low-calorie day and the on-days as high-calorie days. This synchronizes the calorie cycle with the dosing cycle. Higher anabolic signal on high-fuel days, recovery and partial cleanup on low-fuel days. It works because IGF-1 LR3’s 20–30 hour half-life means a single day off creates a real signaling gap.

Timing

Post-workout is the strongest window. Resistance training acutely upregulates IGF-1 receptor sensitivity in worked muscle, and the post-workout glucose uptake amplifies the GLUT4 effect without dropping you into hypoglycemia. Inject within 30–60 minutes after training. If you’re not training that day, morning dose is fine — just have carbs available.

Avoid pre-bed dosing unless you’re eating right before. Hypoglycemia in your sleep is no fun and the bigger GH pulse during deep sleep is already going to amplify the IGF-1 signal anyway.

What to Watch

Bloodwork before and after a few cycles: fasting glucose, HbA1c, fasting insulin, IGF-1 levels. The big risk markers are insulin sensitivity and visceral organ growth (palpable gut distention, particularly with extended high-dose use). 10-day cycles essentially eliminate the gut growth concern, but track insulin sensitivity over multiple cycles.

No traditional PCT needed. LR3 doesn’t suppress endogenous testosterone or HPG function. Receptor resensitization happens during the off-window automatically.

Stacking Recommendations

By Law 5 (Independent Receptor Stacking), the compounds that stack well with IGF-1 LR3 are the ones hitting different receptors and pathways. Stacking another IGF-1R agonist gives you receptor competition, not synergy. Hitting independent pathways is where the real multiplication happens.

Stack Compound	Pathway	Why It Synergizes	Where to Source
BPC-157	Angiogenesis / VEGF / FAK-paxillin	Independent healing pathway. While LR3 drives growth, BPC-157 builds the vasculature and connective tissue to support it. Recovery accelerates without competing for the IGF-1R.	SwissChems
TB-500	Actin regulation, cell migration	Different mechanism from BPC-157 and LR3. Drives endothelial and keratinocyte migration to injury sites. Pairs cleanly without overlap.	SwissChems
MK-677 (Ibutamoren)	Ghrelin receptor (GHS-R1a) → endogenous GH → IGF-1	Use during the LR3 off-window. Keeps IGF-1 elevated through the natural GH axis while the IGF-1 receptor resensitizes from the LR3 cycle. Smart bridging.	SwissChems
Whey isolate + simple carbs	Substrate for protein synthesis + GLUT4-driven glucose uptake	The receptor signal is calling for substrate. Don’t waste the cycle. Whey post-workout, carbs around the dose.	Enhanced Labs

What NOT to stack: native IGF-1, MGF on the same day as LR3, or exogenous insulin. Same-receptor compounds give diminishing returns. Insulin plus LR3 is a hypoglycemia trap unless you’re an experienced bodybuilder running a tight nutrition protocol.

Who Benefits Most

This isn’t a beginner peptide. The ideal profile:

Intermediate-to-advanced bodybuilders past their first few years of training, who have plateaued on natural protocols and standard PED stacks.
Athletes coming off a rest block or injury who want to accelerate the rebuild without going on full HGH.
Anyone running a defined bulking phase who wants to maximize the anabolic window. The 10-day burst lines up perfectly with a hard 10-day surplus.
Older lifters (40+) where natural IGF-1 has dropped and the receptor is still responsive but underutilized.

Not for: beginners, anyone with a personal or family history of cancer (IGF-1 signaling has theoretical mitogenic concerns), uncontrolled diabetes, or anyone running multiple GH-axis compounds at high doses simultaneously.

Realistic Timeline

Timeframe	What to Expect
Day 1–3	Pump increase during training. Glycogen storage feels different. Slight grogginess if carbs aren’t dialed in.
Day 4–7	Visible fullness. Recovery between sets and between sessions improves noticeably. Strength on key lifts trends up.
Day 8–10	Peak fullness. Bodyweight up 4–8 lbs depending on water and glycogen retention. Some of this is real tissue, some is glycogen and fluid.
Days off (2–4 weeks)	Some water and glycogen drop. The retained tissue and any new satellite cell activation is permanent. This is when the cycle’s real gains become visible.
After 3–4 cycles	Cumulative satellite cell activation. New nuclei in muscle fibers. The ceiling on future growth gets raised. This is the real long-term value.

Interesting Perspectives

The 10-day burst is now a documented protocol class. When I was running this back in 2016, the conventional wisdom was 4–6 week cycles. Most online guides still default there. But the research on receptor desensitization shows that 4–6 weeks is exactly long enough for IGF-1R density to start dropping. The 10-day burst protocol — which is now showing up in formal peptide therapy protocols as the “MGF/IGF-1 LR3 burst” approach — minimizes that downregulation. I was running it that way for receptor sensitivity reasons before the published research caught up. The principle generalizes: with high-potency receptor agonists, short pulses beat long infusions.

Hyperplasia vs hypertrophy. This is one of the few compounds where there’s real evidence for hyperplasia — actual new muscle cells, not just bigger existing ones. The MAPK/ERK pathway activation drives satellite cells to divide and donate new nuclei to existing fibers. anabolic steroids primarily increase the size of existing fibers (hypertrophy). LR3 raises the ceiling by adding new nuclei (myonuclear domain expansion). This is why people who run LR3 cycles tend to keep more of their gains long after the compound is gone. Steroids fade. Nuclei stay.

The neural angle no one talks about. IGF-1 receptors are dense in the hippocampus and cortex. IGF-1 crosses the blood-brain barrier through a saturable transport mechanism (research shows an influx rate around 0.4 µL/g·min). LR3, with its extended half-life and IGFBP evasion, plausibly drives more cumulative CNS exposure than native IGF-1. There’s emerging research on IGF-1 supporting BDNF signaling, synaptic plasticity, and neuroprotection. People who run LR3 sometimes report sharper cognition and better mood through the cycle, and the mechanism plausibly explains it. This is unstudied territory but worth flagging.

Sodium chloride vs acetic acid water. Worth knowing: sodium chloride (saline) gives you a smoother shot but somewhat lower stability over weeks. Acetic acid (the standard “BAC water” some peptide protocols call for) gives better stability for in-vial breakdown but the injection burns. For a 10-day protocol, saline is fine — you’re using the vial fast. For a longer protocol where the vial sits in the fridge for 30+ days, acetic acid is the smarter choice. Match the diluent to your dosing window.

Why the gut growth happens. The IGF-1 receptor is expressed in essentially every tissue in the body except cartilage growth plates after closure. This includes intestinal smooth muscle and the visceral organs. Long, high-dose continuous LR3 use is what drives the distended gut some bodybuilders develop. 10-day pulses don’t generate enough cumulative tissue exposure to drive that visceral hypertrophy. Another reason the burst protocol wins.

References

Francis GL, Ross M, Ballard FJ, et al. “Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency.” Journal of Molecular Endocrinology, 1992;8(3):213-223.
Tomas FM, Knowles SE, Owens PC, et al. “Effects of full-length and truncated insulin-like growth factor-I on nitrogen balance and muscle protein metabolism in nitrogen-restricted rats.” Journal of Endocrinology, 1991;128(1):97-105.
Ballard FJ, Wallace JC, Francis GL, et al. “Des(1-3)IGF-I: a truncated form of insulin-like growth factor-I.” International Journal of Biochemistry & Cell Biology, 1996;28(10):1085-1087.
Philippou A, Maridaki M, Halapas A, Koutsilieris M. “The role of the insulin-like growth factor 1 (IGF-1) in skeletal muscle physiology.” In Vivo, 2007;21(1):45-54.
Yakar S, Pennisi P, Wu Y, Zhao H, LeRoith D. “Clinical relevance of systemic and local IGF-I.” Endocrine Development, 2005;9:11-16.
Clemmons DR. “Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes.” Endocrinology and Metabolism Clinics of North America, 2012;41(2):425-443. DOI
Pan W, Kastin AJ. “Interactions of IGF-1 with the blood-brain barrier in vivo and in situ.” Neuroendocrinology, 2000;72(3):171-178.
Goldspink G. “Mechanical signals, IGF-I gene splicing, and muscle adaptation.” Physiology (Bethesda), 2005;20:232-238. DOI

FAQ

What is IGF-1 LR3?

IGF-1 LR3 (Long Arginine 3 IGF-1) is a synthetic 83-amino-acid analog of human insulin-like growth factor 1, engineered with two structural changes that extend its half-life from about 10 minutes to 20–30 hours and increase its functional potency 2–3 fold over native IGF-1. It binds the IGF-1 receptor directly and activates the PI3K/Akt/mTOR and MAPK/ERK signaling pathways, driving protein synthesis and satellite cell proliferation.

What’s the optimal IGF-1 LR3 dosing protocol?

The protocol I dialed in and have run since 2016: reconstitute a 1mg vial with 1mL of sodium chloride water, then inject 100 mcg (10 IU on a U-100 insulin syringe) once daily for 10 days. Eat heavy protein and carbs on dosing days. After 10 days, take 2–4 weeks off and run lower-calorie days to lean back out. You can also pulse 2 days on, 1 day off, with the off-day as a lower-calorie day. Don’t exceed 100 mcg per day.

What are the side effects?

Hypoglycemia is the most common acute side effect — IGF-1 LR3 drives glucose into cells fast, so always have carbs available around your dose. Long-term, high-dose continuous use can cause visceral organ growth (gut distention) and receptor desensitization. The 10-day burst protocol largely avoids both problems. Theoretical mitogenic concerns mean people with personal or family history of cancer should not use it.

Can IGF-1 LR3 be stacked with other compounds?

Yes, but only with compounds hitting independent pathways. BPC-157 and tb-500 stack well — different receptors, complementary healing effects. MK-677 works as a bridge during the off-window to keep IGF-1 elevated through the natural GH axis while the receptor resensitizes. Avoid stacking with native IGF-1 (same receptor, redundant), MGF on the same day (overlapping signaling), or exogenous insulin without strict nutritional control (hypoglycemia risk).

Who should use IGF-1 LR3?

Intermediate-to-advanced bodybuilders past natural plateaus, athletes accelerating recovery from training cycles or injury, lifters running defined bulking blocks, and older athletes (40+) with declining endogenous IGF-1. Not for beginners, not for people with cancer history, not for anyone with uncontrolled diabetes, and not for people running multiple high-dose GH-axis compounds simultaneously.